Leukocyte recruitment during pulmonary Cryptococcus neoformans infection

Immunopharmacology

Volumn 48, Issue 3, 2000, Pages 231-236

  Huffnagle, Gary B ^a   Traynor, Timothy R ^a   McDonald, Rod A ^a   Olszewski, Michal A ^a   Lindell, Dennis M ^a   Herring, Amy C ^a   Toews, Galen B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chemokine receptor; Chemokines; Fungi; Lungs; Lymphocyte; Macrophage

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CONFERENCE PAPER; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE ACTIVITY; LEUKOCYTE MIGRATION; LUNG INFECTION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; CHEMOKINE CCL2; CHEMOKINES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 0034713712     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)00222-8     Document Type: Conference Paper

References (46)

1. Aguirre K., Havell E.A., Gibson G.W., Johnson L.L. Role of tumor necrosis factor alpha and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1995;1725-1731.
2. Aguirre K.M., Johnson L.L. A role for B cells in resistance to Cryptococcus neoformans in mice. Infect. Immun. 65:1997;525-530.
3. Albini A., Ferrini S., Benelli R., Sforzini S., Giunciuglio D., Aluigi M.G., Proudfoot A.E., Alouani S., Wells T.N., Mariani G., Rabin R.L., Farber J.M., Noonan D.M. HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13153-13158.
4. Berkhout T.A., Sarau H.M., Moores K., White J.R., Elshourbagy N., Appelbaum E., Reape R.J., Brawner M., Makwana J., Foley J.J., Schmidt D.B., Imburgia C., McNulty D., Matthews J., O'Donnell K., O'Shannessy D., Scott M., Groot P.H.E., Macphee C. Cloning, in vitro expression and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J. Biol. Chem. 272:1997;16404-16413.
5. Boring L., Gosling J., Chensue S.W., Kunkel S.L., Farese R.V. Jr., Broxmeyer H.E., Charo I.F. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in CC chemokine receptor 2 knockout mice. J. Clin. Invest. 100:1997;2552-2561.
6. Boring L., Gosling J., Monteclaro F.S., Lusis A.J., Tsou C.L., Charo I.F. Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein 1alpha receptors: evidence for two closely linked CC chemokine receptors on chromosome 9. J. Biol. Chem. 271:1996;7551-7558.
7. Casadevall A., Cassone A., Bistoni F., Cutler J.E., Magliani W., Murphy J.W., Polonelli L., Romani L. Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? Med. Mycol. 36(Suppl. 1):1998;95-105.
8. Charo I.F., Myers S.J., Herman A., Franci C., Connolly A.J., Coughlin S.R. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. U. S. A. 91:1994;2752-2756.
9. Collins H.L., Bancroft G.J. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22:1992;1447-1454.
10. Combadiere C., Ahuja S.K., Van Damme J., Tiffany H.L., Gao J.L., Murphy P.M. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J. Biol. Chem. 270:1995;29671-29675.
11. Daugherty B.L., Springer M.S. The beta-chemokine receptor genes CCR1 (CMKBR1), CCR2 (CMKBR2) and CCR3 (CMKBR3) cluster within 285 kb on human chromosome 3p21. Genomics. 41:1997;294-295.
12. Diamond R.D. Cryptococcus neoformans. Mandell G.L., Bennett J.E., Dolin R. Principles and Practice of Infectious Diseases. 1995;2331-2340 Churchill Livingstone, New York.
13. Doyle H.A., Murphy J.W. MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J. Leukocyte Biol. 61:1997;147-155.
14. Frade J.M., Mellado M., del Real G., Gutierrez-Ramos J.C., Lind P., Martinez A.C. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J. Immunol. 159:1997;5576-5584.
15. Franci C., Wong L.M., Van Damme J., Proost P., Charo I.F. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. J. Immunol. 154:1995;6511-6517.
16. Garcia-Zepeda E.A., Combadiere C., Rothenberg M.E., Sarafi M.N., Lavigne F., Hamid Q., Murphy P.M., Luster A.D. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 157:1996;5613-5626.
17. Godiska R., Chantry D., Raport C.J., Schweickart V.L., Trong H.L., Gray P.W. Monocyte chemotactic protein-4: tissue-specific expression and signaling through CC chemokine receptor-2. J. Leukocyte Biol. 61:1997;353-360.
18. Gong X., Gong W., Kuhns D.B., Ben-Baruch A., Howard O.M., Wang J.M. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J. Biol. Chem. 272:1997;11682-11685.
19. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175:1992;1685-1695.
20. + T cells. J. Exp. Med. 173:1991;755-758.
21. Hoag K.A., Lipscomb M.F., Izzo A.A., Street N.E. IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol. 17:1997;733-739.
22. Huffnagle G.B., Chen G.H., Curtis J.L., McDonald R.A., Strieter R.M., Toews G.B. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155:1995;3507-3516.
23. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:1994;35-42.
24. Huffnagle G.B., McNeil L.K., McDonald R.A., Murphy J.W., Toews G.B., Maeda N., Kuziel W.A. Cutting edge: role of CC chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J. Immunol. 163:1999;4642-4646.
25. Huffnagle G.B., Strieter R.M., McDonald R.A., McNeil L.K., Burdick M.D., Kunkel S.L., Toews G.B. Efferent phase production of macrophage inflammatory protein-1alpha (MIP-1alpha) is required for protective cell-mediated immunity to a pulmonary Cryptococcus neoformans infection. J. Immunol. 159:1997;318-327.
26. + T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155:1995;4790-4797.
27. Huffnagle G.B., Toews G.B., Burdick M.D., Boyd M.B., McAllister K.S., McDonald R.A., Kunkel S.L., Strieter R.M. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to C. neoformans. J. Immunol. 157:1996;4529-4536.
28. + T cells. J. Exp. Med. 173:1991;793-800.
29. Kawakami K., Qureshi M.H., Zhang T., Koguchi Y., Shibuya K., Naoe S., Saito A. Interferon-gamma (IFN-gamma)-dependent protection and synthesis of chemoattractants for mononuclear leucocytes caused by IL-12 in the lungs of mice infected with Cryptococcus neoformans. Clin. Exp. Immunol. 117:1999;113-122.
30. Kawakami K., Tohyama M., Qifeng X., Saito A. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun. 65:1997;1307-1312.
31. Kurihara T., Bravo R. Cloning and functional expression of mCCR2, a murine receptor for the CC chemokines JE and FIC. J. Biol. Chem. 271:1996;11603-11607.
32. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1997;1757-1762.
33. Kuziel W.A., Morgan S.J., Dawson T.C., Griffin S., Smithies O., Ley K., Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. U. S. A. 94:1997;12053-12058.
34. Lovchik J., Lipscomb M., Lyons C.R. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans. J. Immunol. 158:1997;1772-1778.
35. Lovchik J.A., Lyons C.R., Lipscomb M.F. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol. 13:1995;116-124.
36. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187:1998;601-608.
37. + T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J. Lab. Clin. Med. 121:1993;765-773.
38. +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol. 144:1990;1472-1477.
39. Moore U.M., Kaplow J.M., Pleass R.D., Castro S.W., Naik K., Lynch C.N., Daly S., Roach A.G., Jaye M., Williams R.J. Monocyte chemoattractant protein-2 is a potent agonist of CCR2B. J. Leukocyte Biol. 62:1997;911-915.
40. Salkowski C.A., Balish E. Inflammatory responses to cryptococcosis in congenitally athymic mice. J. Leukocyte Biol. 49:1991;533-541.
41. Samson M., Labbe O., Mollereau C., Vassart G., Parmentier M. Molecular cloning and functional expression of a new human CC chemokine receptor gene. Biochemistry. 35:1996;3362-3367.
42. Sarafi M.N., Garcia-Zepeda E.A., MacLean J.A., Charo I.F., Luster A.D. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 185:1997;99-109.
43. Traynor T.R., Kuziel W.A., Toews G.B., Huffnagle G.B. CCR2 expression determines T1 vs. T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164:2000;2021-2027.
44. Vecchiarelli A., Casadevall A. Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity. Res. Immunol. 149:1998;321-333. discussion 500-323.
45. Yamagami S., Tanaka H., Endo N. Monocyte chemoattractant protein-2 can exert its effects through the MCP-1 receptor (CC CKR2B). FEBS Lett. 400:1997;329-332.
46. Yamagami S., Tokuda Y., Ishii K., Tanaka H., Endo N. cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor. Biochem. Biophys. Res. Commun. 202:1994;1156-1162.